TGFB1 and central nervous system cancer: To define the functional impact of TGF-β and GITR pathway modulation on anti-glioma immune reactivity, we exposed splenocytes to SD208, one of two GITR agonists, or the combination of both, and assessed their lytic activity against glioma cells in co-culture assays.